BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11125466)

  • 1. DM effort seeks to improve outcomes through prevention, early detection of breast cancer.
    Dis Manag Advis; 2000 Sep; 6(9):140-4, 132. PubMed ID: 11125466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen and breast cancer prevention: what should you tell your patients?
    Goel V
    CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176
    [No Abstract]   [Full Text] [Related]  

  • 3. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 4. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
    Brink S
    US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894
    [No Abstract]   [Full Text] [Related]  

  • 5. Final results from the NSABP Breast Cancer Prevention Trial.
    Oncology (Williston Park); 2005 Dec; 19(14):1800. PubMed ID: 16506633
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK; Ford LG
    Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do we interpret the results of the Breast Cancer Prevention trial?
    Margolese RG
    CMAJ; 1998 Jun; 158(12):1613-4. PubMed ID: 9645175
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk assessment and risk reduction.
    Newman LA; Vogel VG
    Surg Clin North Am; 2007 Apr; 87(2):307-16, vii-viii. PubMed ID: 17498528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of breast cancer chemoprevention: a star is born.
    Morrow M; Jordan VC
    J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
    [No Abstract]   [Full Text] [Related]  

  • 11. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen for breast cancer prevention: a framework for clinical decisions.
    Cykert S; Phifer N; Hansen C
    Obstet Gynecol; 2004 Sep; 104(3):433-42. PubMed ID: 15339751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of breast cancer for women at high risk.
    Chan K; Morris GJ
    Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should you be taking tamoxifen?
    Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen (TAM): the dispute goes on.
    Grilli S
    Ann Ist Super Sanita; 2006; 42(2):170-3. PubMed ID: 17033137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of breast cancer: recommendations and rationale.
    Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventive health program aims to reduce cost, incidence of breast cancer.
    Clin Resour Manag; 2001 Feb; 2(2):26-9, 18. PubMed ID: 11246807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
    McKay A; Latosinsky S; Martin W
    Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast Cancer Prevention Trial shows major benefit, some risk.
    Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.